Best Energy Stocks To Invest In Right Now

tags:LPCN,GWRE,NI,

For many years, it seemed that energy pundits were proposing that the inflection point for renewable energy was just around the corner -- that the day would soon come when solar panels covered our rooftops and electric vehicles spanned our roadways. Having made great strides in reducing costs, however, the alternative energy industry nowadays occupies a prominent position in the nation's energy landscape.

Granted, fossil fuels still play the primary role, but the growing enthusiasm for alternative energy suggests that oil and gas will continue losing ground to green energy sources in the years to come. Unconvinced? Let's take a look at some of the more interesting news from the industry.

Image source: Getty Images.

1. The global appetite for ethanol is growing

Breaking the previous record of 1.2 billion gallons set in 2011, the United States exported 1.4 billion gallons of fuel ethanol in 2017, according to the U.S. Energy Information Administration. The majority of demand came from Brazil, where ethanol exports increased for the fourth consecutive year, reaching 450 million gallons in 2017 and accounting for approximately one-third of all U.S. fuel ethanol exports.

Best Energy Stocks To Invest In Right Now: Lipocine Inc.(LPCN)

Advisors' Opinion:

• [By Max Byerly]

  Get a free copy of the Zacks research report on Lipocine (LPCN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Energy Stocks To Invest In Right Now: Guidewire Software, Inc.(GWRE)

Advisors' Opinion:

• [By Stephan Byrd]

  Linscomb & Williams Inc. decreased its position in Guidewire Software Inc (NYSE:GWRE) by 17.6% in the second quarter, HoldingsChannel.com reports. The firm owned 3,142 shares of the technology company’s stock after selling 673 shares during the period. Linscomb & Williams Inc.’s holdings in Guidewire Software were worth $279,000 at the end of the most recent quarter.

• [By Motley Fool Staff]

  Guidewire Software, Inc. (NYSE:GWRE)Q3 2018 Earnings Conference CallJune 5, 2018, 5:00 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Ethan Ryder]

  Shares of Guidewire Software Inc (NYSE:GWRE) reached a new 52-week high and low during trading on Tuesday . The company traded as low as $96.19 and last traded at $94.10, with a volume of 46042 shares trading hands. The stock had previously closed at $95.82.

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Guidewire Software (GWRE)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Shares of Guidewire Software Inc (NYSE:GWRE) have received an average rating of “Buy” from the thirteen research firms that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and nine have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $95.00.

• [By Garrett Baldwin]

  Money Morning Special Situation Strategist Tim Melvin provides his latest list of stocks that will help you get rich… and stay rich. Check them out right here.

  Three Stocks to Watch Today: GE, AMZN, JD General Electric Co. (NYSE: GE) shares are under pressure after the stock received a downgrade from Swiss bank UBS Group AG (NYSE: UBS). The investment bank cut its price target for GE from $16 to $13. The bank cited ongoing struggles at GE's power division as it continues to lose market share. Amazon.com Inc. (Nasdaq: AMZN) stock is on pace to overtake Apple Inc. (Nasdaq: AAPL) after it became the second company to achieve a $1 trillion market capitalization. The stock price has now doubled in a year thanks to its strong growth in retail sales and cloud computing. Apple needed 38 years to achieve the $1 trillion market cap while Amazon needed just 21 years. With that said, both AMZN and AAPL now comprise 8% of the entire S&P 500 market cap. Shares in JD.com Inc. (Nasdaq: JD) fell more than 5% in pre-market hours. Shares are on the decline after police said that its billionaire founder was arrested last week on charges of sexual assault. Look for additional earnings reports from Ctrip.com International Ltd. (Nasdaq: CTRP), Guidewire Software Inc. (Nasdaq: GWRE), Ollie's Bargain Outlet Holdings Inc. (Nasdaq: OLLI), Vera Bradley Inc. (NYSE: VRA), and Verint Systems Inc. (Nasdaq: VRNT)

  Follow Money Morning on Facebook, Twitter, and LinkedIn.

Best Energy Stocks To Invest In Right Now: NiSource, Inc(NI)

Advisors' Opinion:

• [By Logan Wallace]

  NiSource Inc. (NYSE:NI) has earned a consensus rating of “Hold” from the fifteen brokerages that are currently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, five have given a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $27.00.

• [By Motley Fool Transcribers]

  Nisource Inc  (NYSE:NI)Q4 2018 Earnings Conference CallFeb. 20, 2019, 9:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Max Byerly]

  SG Americas Securities LLC decreased its stake in NiSource Inc. (NYSE:NI) by 75.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,997 shares of the utilities provider’s stock after selling 91,976 shares during the period. SG Americas Securities LLC’s holdings in NiSource were worth $788,000 as of its most recent SEC filing.

• [By Chris Lange]

  The S&P 500 stock posting the largest daily percentage loss in the S&P 500 ahead of the close was NiSource Inc. (NYSE: NI) which fell nearly 12% to $24.80. The stock's 52-week range is $22.44 to $28.11. Volume was about 33 million compared to the daily average volume of 2.5 million.

Best Biotech Stocks To Own For 2019

tags:AMGN,BIIB,ARQL,ALNY,

"Even fools say something worthwhile now and again. Even a blind pig finds an acorn sometimes." - Robert Jordan, The Eye of the World

A Tier 4 biotech concern named Verastem (VSTM) has been a founding member of the model Busted IPO Forum model portfolio since the fourth quarter of last year. The shares spent a few months marking time, but the stock has been on a real roll of late as can be seen from the chart below.

The stock is off some 13% today in early trading. The company took advantages of the recent rise in their shares to announce a ~$35 million secondary offering priced at $4.50 a share today. If you believe all the positive analyst commentary around this attractive developmental name, the rally maybe only beginning and this will turn out to a buyable dip.

Best Biotech Stocks To Own For 2019: Amgen Inc.(AMGN)

Advisors' Opinion:

• [By Cory Renauer]

  The market for complex therapies that train living cells to attack cancer is taking baby steps, but there's still a lot of enthusiasm for experimental drugs coming through the pipeline from bluebird bio (NASDAQ:BLUE) and it's big biotech partner Celgene (NASDAQ:CELG). That enthusiasm fell a notch after Amgen (NASDAQ:AMGN) released exciting data from a handful of patients that suggests it's found a much easier way to achieve the same goal. 

• [By Keith Speights]

  Amgen Inc. (NASDAQ:AMGN) and Pfizer Inc. (NYSE:PFE) actually have quite a bit in common. They co-market one of the world's best-selling drugs, Enbrel. They both face some headwinds with declining sales of older drugs. Each company has promising new drugs. And both stocks are up by nearly the same percentage over the last 12 months.

• [By Max Byerly]

  Amgen (NASDAQ: AMGN) and aTyr Pharma (NASDAQ:LIFE) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, analyst recommendations and institutional ownership.

• [By Todd Campbell, Chris Neiger, and Sean Williams]

  Whirlpool Corporation (NYSE:WHR), Amgen Inc. (NASDAQ:AMGN), and Microsoft Corporation (NASDAQ:MSFT) are very different companies, but they all share one thing in common: Our Motley Fool contributors think now's a good time to add them to dividend portfolios. What makes these companies special? Read on to learn why Whirlpool could be a bargain-bin buy because of tariffs, Amgen could benefit from dividend growth thanks to new drugs, and Microsoft's big bet on the cloud makes it a savvy buy.

• [By Keith Speights]

  It's a big drugmaker with a blockbuster immunology drug as its top-selling product. It pays an attractive dividend. And it faces some uncertainties. This description fits Amgen (NASDAQ:AMGN), but it applies just as well to Johnson & Johnson (NYSE:JNJ).

Best Biotech Stocks To Own For 2019: Biogen Idec Inc(BIIB)

Advisors' Opinion:

• [By Chris Lange]

  The S&P 500 stock posting the largest daily percentage gain ahead of the close was Biogen Inc. (NASDAQ: BIIB) which traded up about 19% at $355.17. The stock's 52-week range is $249.17 to $370.57. Volume was over 12 million compared to the daily average volume of 1.6 million.

• [By Chris Lange]

  Short interest in Biogen Inc. (NASDAQ: BIIB) decreased to 4.29 million shares from the previous 4.73 million. The stock recently traded at $344.10, within a 52-week range of $249.17 to $370.57.

• [By Brian Orelli]

  Data source: Alkermes.

  What happened with Alkermes this quarter? Sales of opioid and alcohol-dependence drug Vivitrol increased 11% year over year as states including Michigan, Pennsylvania, California, Florida, and Kentucky increase coverage of the drug as a treatment option for patients suffering from substance-use disorder. Schizophrenia drug Aristada saw sales increase 72% year over year and 35% quarter over quarter, thanks to the launch of Aristada Initio, which helps patients get started on the drug while hospitalized. Alkermes estimates it captured 29% of new prescriptions for long-acting aripiprazole, the active ingredient in Aristada. Ampyra, which goes by Fampyra outside the U.S., brought in $38.8 million, basically flat year over year, which wasn't bad since a generic launched in the U.S. last year. Manufacturing and royalty revenues for Risperdal Consta, Invega Sustenna, and Invega Trinza were up about 4% year over year. Fourth-quarter revenue also included a one-time payment of $26.7 million, which came from the sale of certain royalty streams by Zealand Pharma to Royalty Pharma. In November, Alkermes reported positive data from a second phase-3 clinical trial for schizophrenia drug ALKS 3831 that showed patients taking the drug had lower weight gain than those taking olanzapine. In December, Alkermes and its partner Biogen (NASDAQ:BIIB) filed for Food and Drug Administration (FDA) approval of diroximel fumarate, which Biogen plans to market under the name Vumerity. In January, Alkermes got bad news from the FDA when the agency turned down the marketing application for its depression drug ALKS 5461.

  Image source: Getty Images.

• [By Keith Speights]

  Investors haven't been happy with either Biogen (NASDAQ:BIIB) or Celgene (NASDAQ:CELG) lately. But the level of discontent is much higher with Celgene. The biotech stock has dropped more than 20% so far in 2018, compared to a single-digit percentage decline for Biogen.

Best Biotech Stocks To Own For 2019: ArQule Inc.(ARQL)

Advisors' Opinion:

• [By Max Byerly]

  Get a free copy of the Zacks research report on ArQule (ARQL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Lisa Levin] Gainers Foot Locker, Inc. (NYSE: FL) rose 15.3 percent to $53.50 in pre-market trading after the company reported better-than-expected results for its first quarter. Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 10.4 percent to $4.58 in pre-market trading. Evofem Biosciences reported closing of public offering of common stock and warrants. Resonant Inc. (NASDAQ: RESN) rose 7.3 percent to $4.88 in pre-market trading after declining 1.94 percent on Thursday. SolarEdge Technologies, Inc. (NASDAQ: SEDG) shares rose 5.7 percent to $59.65 in pre-market trading after falling 8.43 percent on Thursday. Yirendai Ltd. (NYSE: YRD) rose 5 percent to $30.00 in pre-market trading after reporting Q1 results. Deckers Outdoor Corp (NYSE: DECK) rose 4.9 percent to $108.75 in pre-market trading after reporteingd better-than-expected results for its fiscal fourth quarter. Blue Apron Holdings, Inc. (NYSE: APRN) rose 4.2 percent to $3.21 in pre-market trading after gaining 3.70 percent on Thursday. Recro Pharma, Inc. (NASDAQ: REPH) rose 4 percent to $5.85 in pre-market trading after dropping 54.67 percent on Thursday. ArQule, Inc. (NASDAQ: ARQL) rose 3.8 percent to $4.70 in pre-market trading after gaining 4.86 percent on Thursday. Babcock & Wilcox Enterprises, Inc. (NYSE: BW) shares rose 2.9 percent to $2.85 in pre-market trading after climbing 7.78 percent on Thursday. Bilibili Inc. (NASDAQ: BILI) shares rose 2.5 percent to $14.20 in pre-market trading after surging 11.33 percent on Thursday.

  Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

• [By Maxx Chatsko]

  Shares of development-stage biopharma ArQule (NASDAQ:ARQL) rose nearly 17% today after the company announced two appointments to its management team in two newly created positions. Dr. Marc Schegerin will serve as senior vice president, corporate strategy, communication, and finance. Dr. Shirish Hirani will serve as senior vice president, program management and product planning. 

• [By Cory Renauer]

  What's behind these dramatic gains? Read on to find out.

  Company Gain in H1 2018 Market Cap Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) 270% $1.19 billion ArQule, Inc. (NASDAQ:ARQL) 235% $482 million Endocyte, Inc. (NASDAQ:ECYT) 222% $959 million Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) 205% $3.99 billion

  Data source: YCharts.

• [By Logan Wallace]

  ValuEngine downgraded shares of ArQule (NASDAQ:ARQL) from a strong-buy rating to a buy rating in a research report sent to investors on Saturday.

  Several other brokerages also recently issued reports on ARQL. Zacks Investment Research upgraded shares of ArQule from a hold rating to a buy rating and set a $2.75 target price for the company in a research note on Tuesday, May 8th. B. Riley set a $4.00 target price on shares of ArQule and gave the company a buy rating in a research note on Monday, March 26th. Roth Capital raised their target price on shares of ArQule from $5.00 to $6.00 and gave the company a buy rating in a research note on Tuesday, April 17th. BidaskClub upgraded shares of ArQule from a hold rating to a buy rating in a research note on Saturday, May 19th. Finally, Leerink Swann upgraded shares of ArQule from a market perform rating to an outperform rating in a research note on Thursday, April 5th. One research analyst has rated the stock with a sell rating, six have issued a buy rating and one has issued a strong buy rating to the company. The company has an average rating of Buy and a consensus price target of $5.35.

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on ArQule (ARQL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Biotech Stocks To Own For 2019: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors' Opinion:

• [By Cory Renauer]

  If approved, Tegsedi will run directly into competition with Alnylam's (NASDAQ:ALNY) recently approved treatment for the limited population of ATTR patients, Onpattro. Inotersen and Onpattro haven't been tested in a head-to-head study, but most analysts expect Alnylam's drug to gain a much larger share of the limited space than Akcea's.

• [By Keith Speights]

  It's not exactly David vs. Goliath. However, Bellicum Pharmaceuticals (NASDAQ:BLCM) and Alnylam Pharmaceuticals (NASDAQ:ALNY) are definitely in different leagues right now. Both are clinical-stage biotechs, but Bellicum's market cap is less than $350 million while Alnylam's market cap is close to $10 billion.

• [By Keith Speights]

  Speaking of competition, Ionis should have its hands full battling rivals for Tegsedi assuming the drug wins approval. Alnylam (NASDAQ:ALNY) anticipates winning FDA approval for its hATTR drug patisiran within a few weeks. Because the FDA delayed its decision on Tegsedi, Alnylam appears to be in position to reach the market first. In addition to its first-mover advantage, patisiran appears to have an edge over Tegsedi in efficacy and safety based on clinical data for the two drugs. 

• [By Jim Crumly]

  You would think that when a drug company that's been working for 16 years to develop drugs using a novel therapeutic approach wins its first-ever approval from the U.S. Food and Drug Administration (FDA), confetti would fall from the ceiling and its investors would be celebrating a huge stock gain the next day. That didn't happen this week for shareholders of Alnylam Pharmaceuticals (NASDAQ:ALNY), with shares dropping 6.6% the day after the announcement, and there were two main reasons for that.

• [By Shane Hupp]

  Alnylam Pharmaceuticals (NASDAQ:ALNY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Although we are pleased with Alnylam’s broad and promising pipeline, we note that most candidates are in their early or mid stages of development. These candidates still have a long way to go before hitting the market. Currently, Alnylam depends heavily on Onpattro for growth. We also note that gaining approval for pipeline candidates has become more difficult now.  However,  In August, Alnylam got a significant boost with the approval of Onpattro (patisiran), a first-of-its-kind RNA interference (RNAi) therapeutic, both in the United States and in Europe, for the treatment of the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis in adults. This is the first approved candidate for the company and hence should drive revenues. Loss estimates have remained stable ahead of the Q3 earnings release.”

• [By Stephan Byrd]

  Alnylam Pharmaceuticals (NASDAQ:ALNY) was downgraded by investment analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research note issued on Wednesday.

Analysts Expect Vocera Communications Inc (VCRA) Will Announce Quarterly Sales of $34.20 Million

Wall Street analysts expect that Vocera Communications Inc (NYSE:VCRA) will announce $34.20 million in sales for the current quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Vocera Communications’ earnings, with the lowest sales estimate coming in at $33.06 million and the highest estimate coming in at $34.78 million. Vocera Communications posted sales of $40.24 million during the same quarter last year, which suggests a negative year-over-year growth rate of 15%. The company is scheduled to report its next quarterly earnings results on Thursday, April 25th.

According to Zacks, analysts expect that Vocera Communications will report full-year sales of $198.30 million for the current financial year, with estimates ranging from $186.10 million to $249.90 million. For the next year, analysts forecast that the business will report sales of $215.58 million, with estimates ranging from $194.00 million to $224.36 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that follow Vocera Communications.

Get Vocera Communications alerts:

Vocera Communications (NYSE:VCRA) last posted its earnings results on Thursday, February 7th. The communications equipment provider reported $0.18 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.18. Vocera Communications had a negative return on equity of 3.37% and a negative net margin of 5.39%. The firm had revenue of $48.88 million for the quarter, compared to analysts’ expectations of $49.82 million. During the same period last year, the firm earned $0.22 EPS. The company’s quarterly revenue was up 10.8% on a year-over-year basis.

Several equities research analysts recently issued reports on the company. Zacks Investment Research upgraded Vocera Communications from a “hold” rating to a “buy” rating and set a $35.00 price objective on the stock in a report on Wednesday, October 24th. Chardan Capital cut Vocera Communications from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $46.00 to $33.00 in a report on Monday, February 11th. Cantor Fitzgerald reiterated a “buy” rating and issued a $37.00 price objective on shares of Vocera Communications in a report on Thursday, February 7th. Dougherty & Co cut Vocera Communications from a “buy” rating to a “neutral” rating in a report on Monday, January 14th. They noted that the move was a valuation call. Finally, ValuEngine cut Vocera Communications from a “strong-buy” rating to a “buy” rating in a report on Friday, February 8th. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $38.33.

VCRA stock traded up $0.25 during trading on Friday, hitting $30.14. The stock had a trading volume of 390,831 shares, compared to its average volume of 799,291. The company has a current ratio of 4.52, a quick ratio of 4.46 and a debt-to-equity ratio of 0.69. Vocera Communications has a twelve month low of $22.43 and a twelve month high of $42.60. The stock has a market cap of $919.16 million, a price-to-earnings ratio of -177.29 and a beta of 0.31.

In other Vocera Communications news, Director Sharon O’keefe sold 4,000 shares of the business’s stock in a transaction on Tuesday, November 27th. The shares were sold at an average price of $38.00, for a total value of $152,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel Douglas Alan Carlen sold 1,990 shares of the business’s stock in a transaction on Friday, February 15th. The stock was sold at an average price of $30.31, for a total transaction of $60,316.90. The disclosure for this sale can be found here. In the last three months, insiders sold 88,243 shares of company stock worth $3,415,919. 4.90% of the stock is owned by corporate insiders.

Several large investors have recently bought and sold shares of VCRA. Janus Henderson Group PLC acquired a new position in shares of Vocera Communications in the third quarter worth $23,805,000. Conestoga Capital Advisors LLC grew its stake in shares of Vocera Communications by 14.3% in the third quarter. Conestoga Capital Advisors LLC now owns 1,783,535 shares of the communications equipment provider’s stock worth $65,242,000 after acquiring an additional 223,565 shares in the last quarter. Marshall Wace LLP acquired a new position in shares of Vocera Communications in the third quarter worth $8,040,000. Emerald Advisers LLC grew its stake in shares of Vocera Communications by 34.9% in the fourth quarter. Emerald Advisers LLC now owns 666,614 shares of the communications equipment provider’s stock worth $26,231,000 after acquiring an additional 172,572 shares in the last quarter. Finally, Emerald Mutual Fund Advisers Trust grew its stake in shares of Vocera Communications by 34.7% in the fourth quarter. Emerald Mutual Fund Advisers Trust now owns 616,382 shares of the communications equipment provider’s stock worth $24,255,000 after acquiring an additional 158,947 shares in the last quarter.

About Vocera Communications

Vocera Communications, Inc provides secure, integrated, and intelligent communication and workflow solutions that empowers mobile workers in healthcare, hospitality, energy, and other mission-critical mobile work environments in the United States and internationally. The company's communication solution could be integrated with other clinical systems, including electronic health records, nurse call systems, and patient monitoring, as well as to provide critical data, alerts, alarms, and clinical context that enable workflow.

Featured Article: Stock Symbol

Get a free copy of the Zacks research report on Vocera Communications (VCRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Tuesday’s Biggest Winners and Losers in the S&P 500

February 19, 2019: The S&P 500 closed flat at 2,779.63. The DJIA closed flat at 25,893.28. Separately, the Nasdaq closed up 0.2% at 7,486.77.

Monday was a relatively positive day for the broad U.S. markets. We are now reaching the point in earnings season where more retailers will be reporting. Walmart led the Dow to start the truncated trading week. Crude oil also saw a nice gain for the day. The S&P 500 sectors were mostly positive. The most positive sectors were materials and utilities up 0.7% and 0.6%, respectively. The worst performing sector was health care, down 0.2%.

Crude oil was last seen up 0.9% at $56.09.

Gold was last seen trading up 1.6% at $1,342.70.

The S&P 500 stock posting the largest daily percentage loss ahead of the close was Allegion PLC (NYSE: ALLE) which traded down about 4% at $87.79. The stock's 52-week range is $73.85 to $94.30. Volume was about 1.8 million compared to the daily average volume of just over half a million.

The S&P 500 stock posting the largest daily percentage gain in the S&P 500 ahead of the close was Freeport McMoRan Inc. (NYSE: FCX) which rose by about 5% to $12.87. The stock's 52-week range is $9.60 to $19.74. Volume was about 32 million compared to the daily average volume of 22.9 million.

Hersha Hospitality Trust (HT) Expected to Post Earnings of $0.58 Per Share

Wall Street analysts expect that Hersha Hospitality Trust (NYSE:HT) will announce earnings per share of $0.58 for the current fiscal quarter, Zacks reports. Nine analysts have provided estimates for Hersha Hospitality Trust’s earnings, with the highest EPS estimate coming in at $0.60 and the lowest estimate coming in at $0.56. Hersha Hospitality Trust reported earnings of $0.48 per share during the same quarter last year, which indicates a positive year over year growth rate of 20.8%. The firm is expected to issue its next quarterly earnings results after the market closes on Monday, February 25th.

On average, analysts expect that Hersha Hospitality Trust will report full year earnings of $2.18 per share for the current fiscal year, with EPS estimates ranging from $2.16 to $2.20. For the next financial year, analysts forecast that the business will report earnings of $2.32 per share, with EPS estimates ranging from $1.99 to $2.61. Zacks’ earnings per share averages are an average based on a survey of sell-side research firms that that provide coverage for Hersha Hospitality Trust.

Get Hersha Hospitality Trust alerts:

Several equities analysts have recently weighed in on HT shares. Zacks Investment Research cut Hersha Hospitality Trust from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 23rd. ValuEngine cut Hersha Hospitality Trust from a “hold” rating to a “sell” rating in a report on Wednesday, October 24th. Deutsche Bank set a $19.00 price objective on Hersha Hospitality Trust and gave the company a “hold” rating in a report on Thursday, October 25th. B. Riley set a $19.00 price objective on Hersha Hospitality Trust and gave the company a “hold” rating in a report on Thursday, October 25th. Finally, Robert W. Baird set a $20.00 price objective on Hersha Hospitality Trust and gave the company a “hold” rating in a report on Thursday, October 25th. Three analysts have rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $20.42.

Shares of NYSE HT traded up $0.32 during mid-day trading on Monday, hitting $18.64. The company had a trading volume of 314,136 shares, compared to its average volume of 464,413. The stock has a market capitalization of $734.86 million, a price-to-earnings ratio of 8.63, a PEG ratio of 1.87 and a beta of 1.43. The company has a debt-to-equity ratio of 1.09, a current ratio of 0.45 and a quick ratio of 0.45. Hersha Hospitality Trust has a one year low of $16.50 and a one year high of $24.16.

In related news, Director Thomas J. Hutchison III sold 10,000 shares of the firm’s stock in a transaction dated Thursday, December 27th. The shares were sold at an average price of $16.94, for a total value of $169,400.00. Following the completion of the sale, the director now directly owns 75,510 shares in the company, valued at approximately $1,279,139.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Neil H. Shah bought 3,000 shares of the business’s stock in a transaction that occurred on Friday, December 21st. The stock was purchased at an average price of $16.84 per share, with a total value of $50,520.00. Following the completion of the purchase, the insider now directly owns 326,752 shares in the company, valued at approximately $5,502,503.68. The disclosure for this purchase can be found here. Company insiders own 10.30% of the company’s stock.

Large investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its position in Hersha Hospitality Trust by 1.0% during the third quarter. Vanguard Group Inc. now owns 5,776,695 shares of the real estate investment trust’s stock worth $130,958,000 after acquiring an additional 56,252 shares during the last quarter. Vanguard Group Inc lifted its position in Hersha Hospitality Trust by 1.0% during the third quarter. Vanguard Group Inc now owns 5,776,695 shares of the real estate investment trust’s stock worth $130,958,000 after acquiring an additional 56,252 shares during the last quarter. SG Capital Management LLC acquired a new stake in Hersha Hospitality Trust during the fourth quarter worth approximately $4,756,000. MetLife Investment Advisors LLC lifted its position in Hersha Hospitality Trust by 26.2% during the third quarter. MetLife Investment Advisors LLC now owns 26,742 shares of the real estate investment trust’s stock worth $606,000 after acquiring an additional 5,554 shares during the last quarter. Finally, Virginia Retirement Systems ET AL lifted its position in Hersha Hospitality Trust by 24.4% during the third quarter. Virginia Retirement Systems ET AL now owns 150,700 shares of the real estate investment trust’s stock worth $3,416,000 after acquiring an additional 29,600 shares during the last quarter. Institutional investors and hedge funds own 97.76% of the company’s stock.

Hersha Hospitality Trust Company Profile

Hersha Hospitality Trust (HT) is a self-advised real estate investment trust in the hospitality sector, which owns and operates high quality upscale hotels in urban gateway markets and coastal destinations. The Company's 49 hotels totaling 7,730 rooms are located in New York, Washington, DC, Boston, Philadelphia, South Florida and select markets on the West Coast.

Read More: Cost of Goods Sold (COGS)

Get a free copy of the Zacks research report on Hersha Hospitality Trust (HT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Heal Care Stocks For 2019

tags:JLS,CYOU,JAZZ,CRHM,,OMER,

Nobody wants to use the 'B' word, but a bubble is upon us, a growing number of market watchers are warning.

And it could pop sooner than many expect, Centricus Asset Management Fund Manager Ralph Jainz said Monday, joining a long list of financial players casting doubt on the strength of the market's current bull run.

"Nobody wants to talk about this being a bubble. It's the greatest asset inflation bubble we have seen in 20 years," Jainz said during an appearance on CNBC's "Squawk Box Europe."

There is wide disagreement over whether markets have further to climb or whether we'll see a spectacular market correction. Investing titan Mark Mobius recently predicted an impending correction of up to 30 percent, while others see no cause for concern.

Hot Heal Care Stocks For 2019: Nuveen Mortgage Opportunity Term Fund(JLS)

Advisors' Opinion:

• [By Joseph Griffin]

  Nuveen Mortgage Opportunity Term Fund (NYSE:JLS) declared a monthly dividend on Wednesday, August 1st, NASDAQ reports. Shareholders of record on Wednesday, August 15th will be given a dividend of 0.113 per share on Tuesday, September 4th. This represents a $1.36 annualized dividend and a yield of 5.72%. The ex-dividend date is Tuesday, August 14th.

Hot Heal Care Stocks For 2019: Changyou.com Limited(CYOU)

Advisors' Opinion:

• [By Ethan Ryder]

  Shenzhen Xunlei Networking Technologies (NASDAQ: XNET) and Changyou (NASDAQ:CYOU) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

• [By Rick Munarriz]

  Just one segment of the Chinese online advertising, search, and gaming specialist mustered a year-over-year gain for both the quarter and all of 2018. But investors seem to prefer the sum-of-the-parts coverage that Sohu provides. Spun-off subsidiaries Sogou (NYSE:SOGO) and Changyou.com (NASDAQ:CYOU) -- representing Sohu's search and gaming operations, respectively -- were inching lower hours into Friday's trading day as Sohu shares were drifting higher.

• [By Motley Fool Transcribers]

  ChangYou.com  (NASDAQ:CYOU)Q4 2018 Earnings Conference CallFeb. 01, 2019, 12:30 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Ethan Ryder]

  Changyou.Com Ltd (NASDAQ:CYOU)’s share price reached a new 52-week low during trading on Thursday . The stock traded as low as $15.57 and last traded at $15.67, with a volume of 2540 shares changing hands. The stock had previously closed at $15.83.

• [By Rick Munarriz]

  Continuing its turnaround may seem to be an applause-worthy event. This is the third quarter in a row that year-over-year revenue growth tops 20%. However, weak guidance and continuing softness in its flagship display advertising business are sending the stock that was hitting two-year highs just six months ago to fresh 10-year lows. Spun-off subsidiaries Sogou (NYSE:SOGO) and Changyou.com (NASDAQ:CYOU) are also moving lower on Wednesday. 

• [By Keith Noonan, George Budwell, and Maxx Chatsko]

  We asked three Motley Fool contributors to profile a stock that they believe is trading at a substantial discount and has what it takes to be a long-term winner. Read on to see why they identified A.O. Smith (NYSE:AOS), GlaxoSmithKline (NYSE:GSK), and Changyou.com (NASDAQ:CYOU) as top value stocks to buy this September. 

Hot Heal Care Stocks For 2019: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors' Opinion:

• [By Keith Speights]

  But at least three of the biotechs singled out by the FDA deserve to be on another list -- investors' buy lists. Here's why Celgene (NASDAQ:CELG), Gilead Sciences (NASDAQ:GILD), and Jazz Pharmaceuticals (NASDAQ:JAZZ) look like great stock picks right now.

• [By Max Byerly]

  Here are some of the news headlines that may have impacted Accern’s rankings:

  Get Jazz Pharmaceuticals alerts: Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sle… (advfn.com) Jazz Pharmaceuticals (JAZZ) Given a $194.00 Price Target at Royal Bank of Canada (americanbankingnews.com) Analyzing Jazz Pharmaceuticals (JAZZ) & Celyad (CYAD) (americanbankingnews.com) Global Marine Pharmaceuticals Market Growing at a CAGR of 7.28% to 2022 (empowerednews.net) Physicians Unaware of Neurologic Effects Related to Obstructive Sleep Apnea, Finds Jazz Pharmaceuticals Survey (sleepreviewmag.com)

  Shares of Jazz Pharmaceuticals traded up $1.75, hitting $170.75, during trading on Friday, MarketBeat reports. 928,650 shares of the company were exchanged, compared to its average volume of 466,308. The firm has a market capitalization of $10.11 billion, a price-to-earnings ratio of 17.86, a price-to-earnings-growth ratio of 0.87 and a beta of 0.97. Jazz Pharmaceuticals has a fifty-two week low of $128.58 and a fifty-two week high of $171.76. The company has a quick ratio of 2.88, a current ratio of 3.00 and a debt-to-equity ratio of 0.55.

• [By Lisa Levin]

   

  Companies Reporting After The Bell Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion. Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion. The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion. Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million. Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion. LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion. Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion. TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million. The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million. A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion. Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million. Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million. ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million. KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13
• [By Logan Wallace]

  Swiss National Bank trimmed its holdings in shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) by 13.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 192,000 shares of the specialty pharmaceutical company’s stock after selling 29,100 shares during the quarter. Swiss National Bank owned 0.32% of Jazz Pharmaceuticals worth $28,990,000 at the end of the most recent reporting period.

Hot Heal Care Stocks For 2019: CRH Medical Corporation(CRHM)

Advisors' Opinion:

• [By Shane Hupp]

  Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp lessened its holdings in shares of CRH Medical Corp (NYSEAMERICAN:CRHM) by 36.4% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 867,243 shares of the company’s stock after selling 495,404 shares during the period. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned about 1.19% of CRH Medical worth $3,564,000 at the end of the most recent quarter.

Hot Heal Care Stocks For 2019: Hot Tech Stocks To Own For 20()

Advisors' Opinion:

• [By ]

  For example, say "Remind my wife about the party and say don't forget to pick up a bottle of red wine tonight." Siri will know who your spouse is (or will ask you once) and place that in the To: field, and because you said "about" the party, Siri knows you want that in the Subject (Re:) field. You also said "and say," which places words you said after that into the body of the email. This will all save you time!

• [By Ethan Ryder]

  Canaccord Genuity (:) has been given an average recommendation of “N/A” by the zero brokerages that are currently covering the company, Marketbeat reports.

• [By ]

  Sour Patch Kids: These Conversation Hearts are described as "sour then sweet." Phrases include "FRIEND ZONE," "LOL :)" and "OVR IT."

  Sour Patch Kids has Conversation Hearts, which are "sour then sweet." (Photo: Kelly Tyko, USA TODAY)

• [By Max Byerly]

  These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:

  Get Vistagen Therapeutics alerts: Investor’s Alert (Earnings Per Share) – VistaGen Therapeutics Inc (NASDAQ: VTGN) (stocksmarketcap.com) Stock Technical’s & Performances to Explore – VistaGen Therapeutics Inc (NASDAQ: VTGN) (stockspen.com) US STOCKS ON THE MOVE-Media and telecom stocks, H & R Block, TAL Education (nasdaq.com) Tracking the HMA Level on These Shares: VistaGen Therapeutics, Inc. (:VTGN): HMA Reading 1.4214792 (stocknewscaller.com) Keep Your Eyes on Hot Stock of Yesterday— VistaGen Therapeutics, Inc. (VTGN) (stockmarketstop.com)

  Vistagen Therapeutics traded down $0.02, reaching $1.46, on Tuesday, according to MarketBeat Ratings. The company’s stock had a trading volume of 2,930 shares, compared to its average volume of 2,201,613. The stock has a market cap of $34.35 million, a P/E ratio of -0.95 and a beta of 0.29. Vistagen Therapeutics has a 52 week low of $0.69 and a 52 week high of $2.65.

Hot Heal Care Stocks For 2019: Omeros Corporation(OMER)

Advisors' Opinion:

• [By Logan Wallace]

  Omeros Co. (NASDAQ:OMER) rose 5.7% during mid-day trading on Monday . The stock traded as high as $26.62 and last traded at $26.46. Approximately 712,500 shares changed hands during trading, a decline of 29% from the average daily volume of 998,051 shares. The stock had previously closed at $25.04.

• [By ]

  One such company is Omeros Corporation (Nasdaq: OMER). The company is a small-cap biopharma headquartered in Seattle, Washington. The company develops small-molecule and protein therapeutics for application against inflammation, coagulopathies, and disorders of the central nervous system.

• [By Joseph Griffin]

  BidaskClub upgraded shares of Omeros (NASDAQ:OMER) from a sell rating to a hold rating in a research report report published on Wednesday morning.

  Several other research firms also recently issued reports on OMER. HC Wainwright set a $30.00 price objective on shares of Omeros and gave the stock a buy rating in a report on Tuesday, January 23rd. Maxim Group set a $24.00 price objective on shares of Omeros and gave the stock a buy rating in a report on Monday, January 22nd. ValuEngine upgraded shares of Omeros from a sell rating to a hold rating in a report on Friday, February 2nd. Wedbush downgraded shares of Omeros from an outperform rating to a neutral rating and dropped their price objective for the stock from $47.00 to $19.00 in a report on Friday, March 23rd. Finally, WBB Securities restated a buy rating and set a $75.00 price objective on shares of Omeros in a report on Monday, March 26th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the stock. The company has an average rating of Hold and a consensus target price of $25.88.

• [By Cory Renauer]

  None of these biotech stocks are tiny, but they're still small enough to produce the dramatic gains this industry is known for. Here's what you need to know about the catalysts heading their way.

  Company (Symbol) Market Cap Candidate Trial Amarin Corporation plc (NASDAQ:AMRN) $966 million Vascepa Reduce-IT Geron Corporation (NASDAQ:GERN) $1.1 billion Imetelstat IMbark  Omeros Corporation (NASDAQ:OMER) $1.3 billion OMS721 IgA

  Data source: Yahoo! Finance, company filings.

• [By Garrett Baldwin]
  Alphabet Inc. (Nasdaq: GOOGL), Microsoft Corp. (Nasdaq: MSFT), and Apple Inc. (Nasdaq: AAPL) received approval from the U.S. Transportation Department to begin pilot programs for drone delivery services. Missing from the list of approved companies was Amazon.com Inc. (Nasdaq: AMZN). The tech giant has long been an advocate for drone delivery, and its absence came as a surprise to the tech community. It will be a busy day for economic data announcements. Most important will be a report on inflation at 8:30 EDT. Strong price growth has picked up to start the year. This has many economists anticipating that the U.S. Federal Reserve will raise interest rates to stave off additional inflation. Meanwhile, the Bank of England announced that it will hold its benchmark interest rate at 0.5%. The country is still facing economic uncertainty over Brexit. Three Stocks to Watch Today: BKNG, SHLD, F A weak guidance report has shares of Booking Holdings Inc. (Nasdaq: BKNG) off 6% this morning. Although the travel site operator easily topped Wall Street earnings and revenue expectations, the firm once known as Priceline offered a weak 2018 outlook. That sent investors heading for the exits. Sears Holdings Corp. (Nasdaq: SHLD) stock popped more than 16% on Wednesday afternoon. The news came after the embattled retail company announced plans to partner with Amazon.com to sell tires. The plan is part of the company's broader turnaround strategy to make the retail firm profitable again. Ford Motor Co. (NYSE: F) made a stunning announcement on Wednesday. The company said that it will halt production of its F-Series pickup truck. But the move will only be temporary. A fire at a Michigan plant temporarily caused the automotive giant to run out of parts for the top-selling U.S. vehicle. The shutdown could last several weeks, although the company said it has enough parts inventory to last about 12 weeks. Look for additional earnings reports from Nvidia Corp. (Nasdaq: NVDA

Top Stocks To Watch For 2019

tags:TLK,TCON,SB,KYO,ELGX,IGOV,

Cisco Systems Inc. (NASDAQ: CSCO) is scheduled to report its fiscal second-quarter financial results after the markets close on Wednesday. Thomson Reuters consensus estimates are calling for $0.72 in earnings per share (EPS) and $12.41 billion in revenue. The same period of last year reportedly had $0.63 in EPS and $11.89 billion in revenue.

In December, Cisco announced that it would be making a key acquisition. This deal is expected to close in the third quarter of Cisco's fiscal 2019, and it is subject to customary closing conditions and required regulatory approvals.

Cisco is acquiring the privately held Luxtera, a semiconductor company that uses silicon photonics to build integrated optics capabilities for webscale and enterprise data centers, service provider market segments and other customers. Luxtera's technology, design and manufacturing innovation significantly improve chip scale and performance while lowering costs.

Cisco plans to incorporate Luxtera's technology across its intent-based networking portfolio, spanning enterprise, data center and service provider markets.

Top Stocks To Watch For 2019: P.T. Telekomunikasi Indonesia Tbk.(TLK)

Advisors' Opinion:

• [By Joseph Griffin]

  Several analysts have recently issued reports on TLK shares. TheStreet upgraded shares of Telekomnks Indn Prsr Tbk Prshn Prsrn from a “c+” rating to a “b-” rating in a research report on Tuesday, November 6th. ValuEngine upgraded shares of Telekomnks Indn Prsr Tbk Prshn Prsrn from a “sell” rating to a “hold” rating in a research report on Wednesday, October 17th. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The stock currently has an average rating of “Buy”.

  COPYRIGHT VIOLATION WARNING: “Augustine Asset Management Inc. Sells 28,367 Shares of Telekomnks Indn Prsr Tbk Prshn Prsrn-ADR (TLK)” was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/4150140/augustine-asset-management-inc-sells-28367-shares-of-telekomnks-indn-prsr-tbk-prshn-prsrn-adr-tlk.html.

  About Telekomnks Indn Prsr Tbk Prshn Prsrn

• [By Anders Bylund]

  Telekomunikasi Indonesia (NYSE:TLK), the largest telecommunications company in Indonesia, reported first-quarter results on Tuesday, May 2. Top-line sales rose modestly in the first quarter thanks to higher wireless subscriber counts and a healthy broadband business, but those upsides had to overcome a substantial headwind from a mass exodus of old-school wireline subscribers.

• [By Lisa Levin]

  Tuesday afternoon, the telecommunication services shares climbed 1.18 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 7 percent, and Telekomnks Indn Prsr Tbk Prshn Prsrn-ADR (NYSE: TLK), up 3 percent.

• [By Max Byerly]

  Telekomnks Indn Prsr Tbk Prshn Prsrn (NYSE:TLK) was upgraded by equities research analysts at Macquarie from a “neutral” rating to an “outperform” rating in a research report issued to clients and investors on Wednesday, The Fly reports.

• [By Anders Bylund]

  Telekomunikasi Indonesia (NYSE:TLK), the largest telecommunications company in Indonesia, reported second-quarter results on July 31st. The company is losing cellphone subscribers to lower-priced rivals, but management insists that charging higher prices for a higher-quality service is the right way to go.

Top Stocks To Watch For 2019: TRACON Pharmaceuticals, Inc.(TCON)

Advisors' Opinion:

• [By Shane Hupp]

  Get a free copy of the Zacks research report on TRACON Pharmaceuticals (TCON)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Stocks To Watch For 2019: Safe Bulkers Inc(SB)

Advisors' Opinion:

• [By Ethan Ryder]

  Evermore Global Advisors LLC trimmed its holdings in shares of Safe Bulkers, Inc. (NYSE:SB) by 24.1% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 1,997,101 shares of the shipping company’s stock after selling 635,851 shares during the quarter. Safe Bulkers accounts for approximately 2.2% of Evermore Global Advisors LLC’s holdings, making the stock its 14th biggest holding. Evermore Global Advisors LLC’s holdings in Safe Bulkers were worth $6,790,000 at the end of the most recent quarter.

• [By Rich Smith]

  Ocean-going bulk shipper Safe Bulkers (NYSE:SB) reported its fiscal Q1 2018 earnings results on Tuesday -- an "earnings beat" that nudged the company's shares up 2%. But it took until Thursday for the real good news to arrive. Today, all of the sudden, the stock jumped out of its berth and closed 12.2% higher.

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Big Lots, Inc. (NYSE: BIG) shares fell 9.6 percent to $37.01 in pre-market trading after the company reported weaker-than-expected results for its first quarter and issued downbeat earnings forecast. Tilly's, Inc. (NYSE: TLYS) fell 5.7 percent to $12.98 in pre-market trading after rising 12.69 percent on Thursday. Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) fell 4.2 percent to $6.39 in pre-market trading after dropping 4.71 percent on Thursday. Sunlands Online Education Group (NYSE: STG) fell 4.2 percent to $9.13 in pre-market trading. Safe Bulkers, Inc. (NYSE: SB) fell 4.2 percent to $3.42 in pre-market trading after climbing 12.62 percent on Thursday. Ulta Beauty, Inc. (NASDAQ: ULTA) fell 4.1 percent to $236.80 in pre-market trading. Ulta Beauty reported upbeat results for its first quarter, but issued weak second-quarter earnings and sales guidance. GameStop Corp. (NYSE: GME) shares fell 3.8 percent to $12.70 in pre-market trading. GameStop reported in-line earnings for its first quarter, while sales missed estimates. Workday, Inc. (NASDAQ: WDAY) fell 3.2 percent to $126.85 in the pre-market trading session after the company posted Q1 results. Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 3 percent to $57.15 in pre-market trading
• [By Ethan Ryder]

  Safe Bulkers (NYSE:SB) was downgraded by research analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Tuesday.

Top Stocks To Watch For 2019: Kyocera Corporation(KYO)

Advisors' Opinion:

• [By Shane Hupp]

  Taiwan Semiconductor Mfg. (NYSE:TSM) and Kyocera (NYSE:KYO) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

• [By Anders Bylund]

  Shares of Japanese materials giant Kyocera (NYSE:KYO) gained 12.1% in April 2018, according to data from S&P Global Market Intelligence. The stock rode a strong fourth-quarter report to these gains despite zero coverage in the financial press.

• [By Logan Wallace]

  Media stories about Kyocera (NYSE:KYO) have trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Kyocera earned a news sentiment score of 0.11 on Accern’s scale. Accern also gave press coverage about the electronics maker an impact score of 44.7168933477613 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

• [By Max Byerly]

  Media coverage about Kyocera (NYSE:KYO) has trended somewhat positive on Monday, Accern Sentiment reports. Accern scores the sentiment of media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Kyocera earned a coverage optimism score of 0.14 on Accern’s scale. Accern also gave news articles about the electronics maker an impact score of 44.4825472854626 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Top Stocks To Watch For 2019: Endologix, Inc.(ELGX)

Advisors' Opinion:

• [By Brian Orelli]

  Shares of Endologix (NASDAQ:ELGX) were down 37% on Friday after the medical device maker announced disappointing earnings at market close on Thursday. Specifically, revenue decreased 7.9% year over year due to lower U.S. sales of AFX, its endovascular system to treat abdominal aortic aneurysms, and softness in Latin America.

• [By Ethan Ryder]

  Here are some of the news headlines that may have impacted Accern’s analysis:

  Get Endologix alerts: Endologix Reports Positive One-Year Results From the Ovation LUCY Study (dicardiology.com) Endologix, Inc. to Announce Second Quarter 2018 Financial Results on August 9, 2018 (finance.yahoo.com) Stock Under Active Eyes: Endologix, Inc. (ELGX) (bitcoinpriceupdate.review) Endologix, Inc. (ELGX) Given Consensus Recommendation of “Hold” by Brokerages (americanbankingnews.com) Endologix Inc. to Post FY2016 Revenue of ($0.71) Per Share, Leerink Swann Forecasts (ELGX) (bharatapress.com)

  NASDAQ:ELGX traded down $0.09 on Tuesday, hitting $5.42. 4,339 shares of the stock were exchanged, compared to its average volume of 483,122. The firm has a market capitalization of $462.06 million, a PE ratio of -11.31 and a beta of 0.44. The company has a debt-to-equity ratio of 3.58, a current ratio of 2.13 and a quick ratio of 1.37. Endologix has a fifty-two week low of $3.75 and a fifty-two week high of $6.72.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Endologix (ELGX)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Stocks To Watch For 2019: iShares S&P/Citigroup International Treasury Bond Fund(IGOV)

Advisors' Opinion:

• [By Stephan Byrd]

  Keybank National Association OH lowered its stake in iShares International Treasury Bond ETF (NASDAQ:IGOV) by 63.8% during the second quarter, HoldingsChannel reports. The institutional investor owned 60,991 shares of the company’s stock after selling 107,316 shares during the period. Keybank National Association OH’s holdings in iShares International Treasury Bond ETF were worth $3,001,000 as of its most recent SEC filing.

Equities Analysts Issue Forecasts for Snc-Lavalin Group Inc’s FY2018 Earnings (SNC)

Snc-Lavalin Group Inc (TSE:SNC) – Equities research analysts at National Bank Financial lowered their FY2018 earnings per share (EPS) estimates for shares of Snc-Lavalin Group in a report released on Monday, February 11th. National Bank Financial analyst M. Sytchev now expects that the company will post earnings of $0.25 per share for the year, down from their prior forecast of $1.22. National Bank Financial currently has a “Outperform” rating and a $52.00 target price on the stock. National Bank Financial also issued estimates for Snc-Lavalin Group’s Q4 2018 earnings at ($1.62) EPS, Q1 2019 earnings at $0.21 EPS, Q2 2019 earnings at $0.46 EPS and FY2019 earnings at $1.99 EPS.

Get Snc-Lavalin Group alerts:

SNC has been the topic of several other research reports. Royal Bank of Canada dropped their target price on shares of Snc-Lavalin Group from C$58.00 to C$48.00 and set an “outperform” rating on the stock in a report on Tuesday, January 29th. Raymond James set a C$45.00 target price on shares of Snc-Lavalin Group and gave the stock a “market perform” rating in a report on Tuesday. Desjardins downgraded shares of Snc-Lavalin Group from a “buy” rating to a “hold” rating and dropped their target price for the stock from C$72.00 to C$47.00 in a report on Tuesday, January 29th. TD Securities dropped their price objective on shares of Snc-Lavalin Group from C$59.00 to C$47.00 and set a “buy” rating on the stock in a report on Tuesday, January 29th. Finally, CIBC upgraded shares of Snc-Lavalin Group from a “neutral” rating to an “outperform” rating and dropped their price objective for the stock from C$56.00 to C$49.00 in a report on Tuesday, January 29th. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of C$48.78.

Shares of SNC opened at C$33.88 on Thursday. The firm has a market capitalization of $5.97 billion and a P/E ratio of 17.92. Snc-Lavalin Group has a one year low of C$33.30 and a one year high of C$61.54. The company has a current ratio of 0.89, a quick ratio of 0.77 and a debt-to-equity ratio of 72.88.

Snc-Lavalin Group Company Profile

SNC-Lavalin Group Inc provides consulting, design, engineering, construction, and operation and maintenance services worldwide. It operates through Mining & Metallurgy, Oil & Gas, Power, Infrastructure, Atkins, and Capital segments. The company offers various solutions for projects in the aluminum, gold, copper, iron ore, nickel, fertilizer, sulphur, and other projects.

Further Reading: Intrinsic Value

Best Undervalued Stocks To Watch Right Now

tags:SPY,BRT,WD,BLE,ICBK,EARN,

The big news over the weekend has been Facebook Inc.'s (NSDQ:FB) announcement to buy back stock worth $6B, starting in Q1 2017. This was a first in the history of the company. While it can come across as a surprise for a growing company to announce a share repurchase offering, the recent drop in FB stock price could have forced the management into action. The FB stock price is down by over 12% from its October 24th close price of $133.28, all in a matter of 19 trading sessions. The recent downtrend has been in stark contrast to the 27% gain in the stock price through the year up to the October high. Does the management believe that the stock is undervalued at the current levels? What does it mean for investors? (See also: Is Facebook Inc. (FB) Stock A Big Short?)

Facebook's $6B Buyback And What Does It Mean For Investors?

In an 8-K filing with the SEC, dated November 18, Facebook disclosed that the BOD (Board of Directors) had authorized the company to repurchase nearly $6B worth of stock. Quoting from the SEC filing:

Best Undervalued Stocks To Watch Right Now: SPDR S&P 500 ETF (SPY)

Advisors' Opinion:

• [By Javier Hasse]

  Over the last five trading days (May 25–June 1), the Horizons Marijuana Life Sciences Index ETF (OTC: HMLSF) gained 0.6 percent, while the ETFMG Alternative Harvest ETF (NYSE: MJ) lost 1.1 percent. The SPDR S&P 500 ETF Trust (NYSE: SPY) gained 0.45 percent.

• [By Joseph Griffin]

  Alleghany Corp DE reduced its position in shares of SPDR S&P 500 Trust ETF (NYSEARCA:SPY) by 77.4% in the 1st quarter, Holdings Channel reports. The firm owned 46,500 shares of the company’s stock after selling 159,500 shares during the quarter. Alleghany Corp DE’s holdings in SPDR S&P 500 Trust ETF were worth $12,236,000 at the end of the most recent quarter.

• [By Javier Hasse]

  The Horizons Marijuana Life Sciences Index ETF (OTC: HMLSF) gained 3 percent over the five days of the week, while the ETFMG Alternative Harvest ETF (NYSE: MJ) rose 1 percent. The SPDR S&P 500 ETF Trust (NYSE: SPY) slipped 0.55 percent.

• [By ]

  This is a daily chart of the SPDR S&P 500 ETF (NYSE: SPY). In this case, prices fell almost 12%. The subsequent gain of about 8% retraced more than 60% of the loss. Retracements are important to technical analysts and are widely followed by traders at some of the biggest hedge funds. These funds aren't relying on retracements or Fibonacci ratios to make decisions, but they do provide valuable input into their market opinion.

• [By ]

  Yet when it comes to investing, reward often comes from being willing to take on risk. Over the past 10 years, investors who've been willing to look at smaller companies have seen much stronger returns than those who've stuck with the tried-and-true big names that are more familiar to them. When you look at exchange-traded funds tracking indexes composed of companies of different sizes — SPDR S&P 500 (NYSEMKT: SPY) for large companies, SPDR S&P Midcap 400 (NYSEMKT: MDY) for midsize companies and SPDR S&P SmallCap 600 (NYSEMKT: SLY) for small companies — you can put a number on just how much better smaller stocks have done:

• [By ]

  To minimize the risks of put selling, you should only sell put options on stocks or ETFs that you would like to own. For example, if SPDR S&P 500 ETF (NYSE: SPY) is trading at $290 and you would like to buy it on a 10% pullback, you could sell a put at $261 that expires in one to two months and earn income while waiting to buy at your desired price. The caveat is that if SPY falls more than 10% you will still have to buy it at $261.

Best Undervalued Stocks To Watch Right Now: BRT Realty Trust(BRT)

Advisors' Opinion:

• [By Logan Wallace]

  BRT Apartments Corp (NYSE:BRT) – Equities researchers at B. Riley reduced their FY2018 EPS estimates for BRT Apartments in a research report issued on Tuesday, August 21st. B. Riley analyst C. Kucera now forecasts that the financial services provider will post earnings of $0.94 per share for the year, down from their prior forecast of $1.13. B. Riley also issued estimates for BRT Apartments’ Q4 2018 earnings at $0.18 EPS, Q1 2019 earnings at $0.21 EPS, Q2 2019 earnings at $0.22 EPS, Q3 2019 earnings at $0.23 EPS, Q4 2019 earnings at $0.25 EPS and FY2019 earnings at $0.91 EPS.

• [By Joseph Griffin]

  BRT Apartments Corp (NYSE:BRT) announced a quarterly dividend on Tuesday, June 12th, Zacks reports. Shareholders of record on Monday, June 25th will be given a dividend of 0.20 per share by the financial services provider on Friday, July 6th. This represents a $0.80 dividend on an annualized basis and a yield of 6.14%. The ex-dividend date of this dividend is Friday, June 22nd.

• [By Max Byerly]

  Get a free copy of the Zacks research report on BRT Apartments (BRT)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Undervalued Stocks To Watch Right Now: Walker & Dunlop, Inc.(WD)

Advisors' Opinion:

• [By Logan Wallace]

  Boston Partners increased its holdings in Walker & Dunlop, Inc. (NYSE:WD) by 3.1% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,495,943 shares of the financial services provider’s stock after buying an additional 45,657 shares during the period. Boston Partners owned about 4.82% of Walker & Dunlop worth $83,249,000 as of its most recent filing with the Securities & Exchange Commission.

• [By Motley Fool Transcribing]

  Walker & Dunlop (NYSE:WD) Q4 2018 Earnings Conference CallFeb. 6, 2019 8:30 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Stephan Byrd]

  Walker & Dunlop (NYSE: WD) and Medallion Financial (NASDAQ:MFIN) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends.

Best Undervalued Stocks To Watch Right Now: BlackRock Municipal Income Trust II(BLE)

Advisors' Opinion:

• [By Joseph Griffin]

  BlackRock Municipal Income Trust II (NYSEAMERICAN:BLE) announced a monthly dividend on Wednesday, August 1st, NASDAQ reports. Stockholders of record on Wednesday, August 15th will be given a dividend of 0.058 per share on Tuesday, September 4th. This represents a $0.70 dividend on an annualized basis and a dividend yield of 5.16%. The ex-dividend date is Tuesday, August 14th.

• [By Logan Wallace]

  BlackRock Municipal Income Trust II (NYSEAMERICAN:BLE) announced a monthly dividend on Monday, October 1st, NASDAQ reports. Shareholders of record on Monday, October 15th will be paid a dividend of 0.058 per share on Thursday, November 1st. This represents a $0.70 dividend on an annualized basis and a yield of 5.43%. The ex-dividend date of this dividend is Friday, October 12th.

Best Undervalued Stocks To Watch Right Now: County Bancorp, Inc.(ICBK)

Advisors' Opinion:

• [By Max Byerly]

  Southern National Banc. of Virginia (NASDAQ: ICBK) and County Bancorp (NASDAQ:ICBK) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, risk and dividends.

• [By Max Byerly]

  Middlefield Banc (NASDAQ: ICBK) and County Bancorp (NASDAQ:ICBK) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, valuation and earnings.

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on County Bancorp (ICBK)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  County Bancorp (NASDAQ:ICBK) has received an average recommendation of “Hold” from the six research firms that are currently covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $32.75.

• [By Stephan Byrd]

  County Bancorp Inc (NASDAQ:ICBK) President Timothy J. Schneider sold 1,000 shares of the stock in a transaction on Monday, June 4th. The shares were sold at an average price of $27.55, for a total value of $27,550.00. Following the completion of the sale, the president now owns 113,882 shares in the company, valued at $3,137,449.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

• [By Shane Hupp]

  Guaranty Bancorp (NASDAQ:GBNK) and County Bancorp (NASDAQ:ICBK) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership.

Best Undervalued Stocks To Watch Right Now: Ellington Residential Mortgage REIT(EARN)

Advisors' Opinion:

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Ellington Residential Mortgage REIT (EARN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  Ellington Residential (NYSE:EARN) major shareholder Holdings L.P. Blackstone III bought 11,909 shares of Ellington Residential stock in a transaction that occurred on Monday, May 14th. The stock was purchased at an average cost of $11.26 per share, for a total transaction of $134,095.34. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Ellington Residential Mortgage REIT (EARN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  Paloma Partners Management Co purchased a new stake in shares of Ellington Residential Mortgage REIT (NYSE:EARN) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 44,499 shares of the real estate investment trust’s stock, valued at approximately $485,000.

ABCC Token (AT) Reaches One Day Trading Volume of $0.00

ABCC Token (CURRENCY:AT) traded flat against the U.S. dollar during the 24-hour period ending at 0:00 AM E.T. on February 11th. Over the last seven days, ABCC Token has traded flat against the U.S. dollar. ABCC Token has a total market cap of $0.00 and $0.00 worth of ABCC Token was traded on exchanges in the last day. One ABCC Token token can now be bought for $0.0000 or 0.00000000 BTC on exchanges.

Here’s how other cryptocurrencies have performed over the last day:

Get ABCC Token alerts: XRP (XRP) traded 0.7% lower against the dollar and now trades at $0.30 or 0.00008321 BTC. Tether (USDT) traded down 0.5% against the dollar and now trades at $1.00 or 0.00027566 BTC. TRON (TRX) traded 4.2% lower against the dollar and now trades at $0.0246 or 0.00000675 BTC. Stellar (XLM) traded down 2.1% against the dollar and now trades at $0.0772 or 0.00002124 BTC. Binance Coin (BNB) traded 1.7% higher against the dollar and now trades at $9.60 or 0.00264025 BTC. Bitcoin SV (BSV) traded 0.6% lower against the dollar and now trades at $64.98 or 0.01787413 BTC. NEO (NEO) traded up 2.9% against the dollar and now trades at $8.05 or 0.00221303 BTC. VeChain (VET) traded down 1.4% against the dollar and now trades at $0.0039 or 0.00000108 BTC. TrueUSD (TUSD) traded down 0.2% against the dollar and now trades at $1.02 or 0.00027925 BTC. Holo (HOT) traded up 0.9% against the dollar and now trades at $0.0012 or 0.00000033 BTC.

ABCC Token Profile

ABCC Token’s total supply is 61,556,250 tokens. ABCC Token’s official Twitter account is @ABCC_Exchange. The Reddit community for ABCC Token is /r/ABCC. ABCC Token’s official website is abcc.com.

ABCC Token Token Trading

ABCC Token can be purchased on the following cryptocurrency exchanges: ABCC. It is usually not currently possible to purchase alternative cryptocurrencies such as ABCC Token directly using U.S. dollars. Investors seeking to acquire ABCC Token should first purchase Ethereum or Bitcoin using an exchange that deals in U.S. dollars such as Gemini, Changelly or Coinbase. Investors can then use their newly-acquired Ethereum or Bitcoin to purchase ABCC Token using one of the exchanges listed above.

Magnet Price Tops $0.0082 on Exchanges (MAG)

Magnet (CURRENCY:MAG) traded 3.3% higher against the US dollar during the 1 day period ending at 0:00 AM ET on February 11th. Magnet has a total market capitalization of $332,242.00 and $1,130.00 worth of Magnet was traded on exchanges in the last day. One Magnet coin can currently be purchased for approximately $0.0082 or 0.00000227 BTC on exchanges including Cryptopia, CoinExchange, CryptoBridge and BiteBTC. Over the last week, Magnet has traded down 5.1% against the US dollar.

Here’s how similar cryptocurrencies have performed over the last day:

Get Magnet alerts: Tao (XTO) traded flat against the dollar and now trades at $0.22 or 0.00005602 BTC. Syndicate (SYNX) traded down 2.6% against the dollar and now trades at $0.0211 or 0.00000582 BTC. Capricoin (CPC) traded 1.1% lower against the dollar and now trades at $0.25 or 0.00006871 BTC. IslaCoin (ISL) traded flat against the dollar and now trades at $0.17 or 0.00002159 BTC. Monkey Project (MONK) traded 0.7% higher against the dollar and now trades at $0.0404 or 0.00001110 BTC. Piggycoin (PIGGY) traded 0.1% lower against the dollar and now trades at $0.0004 or 0.00000011 BTC. Virtacoinplus (XVP) traded flat against the dollar and now trades at $0.0139 or 0.00000145 BTC. TrustPlus (TRUST) traded flat against the dollar and now trades at $0.0039 or 0.00000060 BTC. Regalcoin (REC) traded 45.7% lower against the dollar and now trades at $0.0049 or 0.00000135 BTC. SuperCoin (SUPER) traded 0% higher against the dollar and now trades at $0.0009 or 0.00000025 BTC.

Magnet Coin Profile

Magnet (MAG) is a PoW/PoS coin that uses the
X11 hashing algorithm. Its genesis date was November 14th, 2017. Magnet’s total supply is 40,542,939 coins and its circulating supply is 40,292,939 coins. The Reddit community for Magnet is /r/magnetwork_io and the currency’s Github account can be viewed here. Magnet’s official Twitter account is @magnetwork_io. Magnet’s official website is magnetwork.io.

Magnet Coin Trading

Magnet can be traded on the following cryptocurrency exchanges: Cryptopia, BiteBTC, CryptoBridge and CoinExchange. It is usually not currently possible to buy alternative cryptocurrencies such as Magnet directly using U.S. dollars. Investors seeking to trade Magnet should first buy Ethereum or Bitcoin using an exchange that deals in U.S. dollars such as GDAX, Gemini or Coinbase. Investors can then use their newly-acquired Ethereum or Bitcoin to buy Magnet using one of the exchanges listed above.

new TradingView.widget({ “height”: 400, “width”: 650, “symbol”: “MAGUSD”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Intesa Sanpaolo (ISP) Given a €2.05 Price Target by Jefferies Financial Group Analysts

Jefferies Financial Group set a €2.05 ($2.38) target price on Intesa Sanpaolo (BIT:ISP) in a report published on Tuesday. The brokerage currently has a neutral rating on the stock.

Other research analysts also recently issued research reports about the company. Royal Bank of Canada set a €2.30 ($2.67) target price on Intesa Sanpaolo and gave the company a neutral rating in a research note on Tuesday, January 1st. Morgan Stanley set a €2.60 ($3.02) target price on Intesa Sanpaolo and gave the company a neutral rating in a research note on Tuesday, November 27th. JPMorgan Chase & Co. set a €2.50 ($2.91) target price on Intesa Sanpaolo and gave the company a neutral rating in a research note on Tuesday, November 6th. Goldman Sachs Group restated a sell rating on shares of Intesa Sanpaolo in a research note on Tuesday, December 25th. Finally, HSBC set a €2.60 ($3.02) target price on Intesa Sanpaolo and gave the company a buy rating in a research note on Friday, November 16th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and eight have assigned a buy rating to the stock. The company currently has a consensus rating of Hold and a consensus target price of €2.63 ($3.06).

Get Intesa Sanpaolo alerts:

Intesa Sanpaolo has a 52-week low of €2.39 ($2.78) and a 52-week high of €3.23 ($3.76).

Intesa Sanpaolo Company Profile

Intesa Sanpaolo S.p.A. provides various banking products and services. It operates through Banca dei Territori, Banking, Internat Subsidiary Banks, Private Banking, and Asset Management business units. The company offers lending and deposit products; corporate, investment banking, and public finance services; industrial credit, factoring, and leasing services; asset management solutions; life and non-life insurance products; and bancassurance and pension fund, and fiduciary services.

Further Reading: Can systematic risk be avoided?

Neurocrine Biosciences Inc (NBIX) Files 10-K for the Fiscal Year Ended on December 31, 2018

Neurocrine Biosciences Inc (NASDAQ:NBIX) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. Neurocrine Biosciences Inc has a market cap of $7.35 billion; its shares were traded at around $81.05 with a P/E ratio of 1350.84 and P/S ratio of 17.99.

For the last quarter Neurocrine Biosciences Inc reported a revenue of $131.5 million, compared with the revenue of $94.52 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $451.2 million, an increase of 179.2% from last year. For the last five years Neurocrine Biosciences Inc had an average revenue decline of 0% a year. The Neurocrine Biosciences Inc had an operating margin of 8.18%, compared with the operating margin of -81.27% a year before. The 10-year historical median operating margin of Neurocrine Biosciences Inc is -476.51%. The profitability rank of the company is 4 (out of 10).

At the current stock price of $81.05, Neurocrine Biosciences Inc is traded at 55.4% discount to its historical median P/S valuation band of $181.92. The P/S ratio of the stock is 17.99, while the historical median P/S ratio is 40.39. The stock lost 2.05% during the past 12 months.

CEO Recent Trades:

CEO Kevin Charles Gorman sold 7,614 shares of NBIX stock on 02/05/2019 at the average price of $88.16. The price of the stock has decreased by 8.06% since.

Directors and Officers Recent Trades:

Chief Development Officer Haig P. Bozigian sold 2,725 shares of NBIX stock on 02/05/2019 at the average price of $88.12. The price of the stock has decreased by 8.02% since.Chief Commercial Officer Eric Benevich sold 1,357 shares of NBIX stock on 02/05/2019 at the average price of $88.01. The price of the stock has decreased by 7.91% since.Chief Regulatory Officer Malcolm Lloyd-smith sold 1,272 shares of NBIX stock on 02/05/2019 at the average price of $88.14. The price of the stock has decreased by 8.04% since.Chief Legal Officer Darin Lippoldt sold 1,225 shares of NBIX stock on 02/05/2019 at the average price of $88.09. The price of the stock has decreased by 7.99% since.Chief Research Officer Dimitri E. Grigoriadis sold 2,445 shares of NBIX stock on 02/05/2019 at the average price of $88.14. The price of the stock has decreased by 8.04% since.

For the complete 20-year historical financial data of NBIX, click here.

Hot Value Stocks To Invest In Right Now

tags:BKEP,OPOF,CASY,

It has been over a week since HyreCar (NASDAQ:HYRE) filed its tiny IPO. MarketWatch reported then that the company raised just $12.5 million by selling 2.5 million shares at $5. The stock has not been impressive since then, hovering around the $5 mark and sitting at $4.97 as of Tuesday morning.

HyreCar's low value may intrigue some investors, but the company suffers from a lot of major problems, such as high losses and an extremely short operating history. Investors should remember that less successful or storied companies will look to take advantage of the currently successful IPO market, and HyreCar's IPO appears to be a prime example of this. There are few reasons to consider this stock moving forward.

Latching on to Ridesharing

In HyreCar's S-1/A filing, the company describes itself as "a unique peer-to-peer car-sharing marketplace" which lets car owners rent their vehicles to drivers who want to work with Uber (UBER) and Lyft. HyreCar takes a fee from drivers and owners, does background checks, insures both of them, and lets drivers rent vehicles for periods as short as one day.

Hot Value Stocks To Invest In Right Now: Blueknight Energy Partners L.P., L.L.C.(BKEP)

Advisors' Opinion:

• [By Ethan Ryder]

  Shares of Blueknight Energy Partners LP Common Stock (NASDAQ:BKEP) have earned an average recommendation of “Hold” from the seven analysts that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating on the company. The average 12 month target price among brokers that have covered the stock in the last year is $4.00.

• [By Ethan Ryder]

  Phillips 66 Partners (NYSE:PSXP) and Blueknight Energy Partners (NASDAQ:BKEP) are both oils/energy companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

• [By Max Byerly]

  Blueknight Energy Partners LP (NASDAQ:BKEP) hit a new 52-week low on Tuesday . The company traded as low as $2.30 and last traded at $2.37, with a volume of 12716 shares traded. The stock had previously closed at $2.35.

Hot Value Stocks To Invest In Right Now: Old Point Financial Corporation(OPOF)

Advisors' Opinion:

• [By Stephan Byrd]

  News coverage about Old Point Financial (NASDAQ:OPOF) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Old Point Financial earned a media sentiment score of 0.01 on Accern’s scale. Accern also assigned press coverage about the bank an impact score of 46.7121766894414 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Hot Value Stocks To Invest In Right Now: Caseys General Stores, Inc.(CASY)

Advisors' Opinion:

• [By Ethan Ryder]

  Brokerages predict that Casey’s General Stores Inc (NASDAQ:CASY) will report earnings of $1.57 per share for the current quarter, according to Zacks. Five analysts have made estimates for Casey’s General Stores’ earnings, with the highest EPS estimate coming in at $1.70 and the lowest estimate coming in at $1.48. Casey’s General Stores posted earnings of $1.28 per share during the same quarter last year, which would suggest a positive year over year growth rate of 22.7%. The firm is expected to announce its next earnings results on Monday, December 10th.

• [By Brian Stoffel]

  It's been a long, hard road for investors in small-town convenience outfit Casey's General Stores (NASDAQ:CASY). While the company's focus on pizza delivery produced huge gains coming out of the Great Recession, the stock has trailed the broader market by over 50 percentage points since July 2016.

• [By Logan Wallace]

  Casey’s General Stores Inc (NASDAQ:CASY) – Equities researchers at Jefferies Financial Group dropped their Q1 2019 earnings estimates for Casey’s General Stores in a research report issued to clients and investors on Tuesday, August 21st. Jefferies Financial Group analyst C. Mandeville now forecasts that the company will post earnings of $1.80 per share for the quarter, down from their previous estimate of $1.83. Jefferies Financial Group has a “Buy” rating and a $134.00 price objective on the stock. Jefferies Financial Group also issued estimates for Casey’s General Stores’ Q3 2019 earnings at $0.55 EPS, FY2019 earnings at $4.67 EPS, Q1 2020 earnings at $2.04 EPS and Q4 2020 earnings at $0.77 EPS.

Amica Mutual Insurance Co. Cuts Holdings in Alphabet Inc (GOOG)

Amica Mutual Insurance Co. reduced its stake in shares of Alphabet Inc (NASDAQ:GOOG) by 6.7% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 18,593 shares of the information services provider’s stock after selling 1,328 shares during the quarter. Alphabet comprises approximately 2.3% of Amica Mutual Insurance Co.’s holdings, making the stock its 5th biggest position. Amica Mutual Insurance Co.’s holdings in Alphabet were worth $22,190,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Ironwood Financial llc grew its position in shares of Alphabet by 111.1% during the 3rd quarter. Ironwood Financial llc now owns 95 shares of the information services provider’s stock valued at $113,000 after acquiring an additional 50 shares during the period. Patton Albertson Miller Group LLC acquired a new stake in shares of Alphabet during the 3rd quarter valued at about $116,000. ELM Advisors LLC acquired a new stake in shares of Alphabet during the 3rd quarter valued at about $138,000. LFA Lugano Financial Advisors SA acquired a new stake in shares of Alphabet during the 3rd quarter valued at about $161,000. Finally, Blackhawk Capital Partners LLC. grew its position in shares of Alphabet by 148.6% during the 2nd quarter. Blackhawk Capital Partners LLC. now owns 174 shares of the information services provider’s stock valued at $194,000 after acquiring an additional 104 shares during the period. 34.12% of the stock is currently owned by institutional investors.

Get Alphabet alerts:

GOOG opened at $1,132.80 on Tuesday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 4.10 and a current ratio of 4.14. Alphabet Inc has a 1-year low of $970.11 and a 1-year high of $1,273.89. The company has a market capitalization of $772.95 billion, a price-to-earnings ratio of 24.99 and a beta of 1.06.

Alphabet (NASDAQ:GOOG) last released its earnings results on Monday, February 4th. The information services provider reported $12.77 earnings per share for the quarter, topping the Zacks’ consensus estimate of $10.86 by $1.91. Alphabet had a net margin of 14.45% and a return on equity of 19.40%. The business had revenue of $39.28 billion for the quarter, compared to analyst estimates of $38.91 billion. During the same period last year, the company posted $9.70 EPS. The business’s revenue was up 21.5% on a year-over-year basis.

In other Alphabet news, VP Amie Thuener O’toole sold 80 shares of the firm’s stock in a transaction that occurred on Tuesday, December 4th. The shares were sold at an average price of $1,103.12, for a total value of $88,249.60. Following the transaction, the vice president now directly owns 388 shares of the company’s stock, valued at approximately $428,010.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Ann Mather sold 194 shares of the firm’s stock in a transaction that occurred on Monday, December 3rd. The stock was sold at an average price of $1,120.68, for a total transaction of $217,411.92. Following the completion of the transaction, the director now directly owns 1,797 shares in the company, valued at $2,013,861.96. The disclosure for this sale can be found here. Insiders sold a total of 89,495 shares of company stock worth $94,244,736 over the last three months. Corporate insiders own 13.11% of the company’s stock.

GOOG has been the topic of a number of analyst reports. BidaskClub upgraded Alphabet from a “strong sell” rating to a “sell” rating in a research report on Thursday, December 13th. Barclays reaffirmed a “buy” rating on shares of Alphabet in a research note on Friday, October 26th. DZ Bank reaffirmed a “buy” rating on shares of Alphabet in a research note on Thursday, October 18th. ValuEngine lowered shares of Alphabet from a “buy” rating to a “hold” rating in a research note on Thursday, October 11th. Finally, Nomura reaffirmed a “buy” rating on shares of Alphabet in a research note on Monday, October 29th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and twenty-nine have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $1,311.71.

COPYRIGHT VIOLATION NOTICE: “Amica Mutual Insurance Co. Cuts Holdings in Alphabet Inc (GOOG)” was reported by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.tickerreport.com/banking-finance/4126419/amica-mutual-insurance-co-cuts-holdings-in-alphabet-inc-goog.html.

Alphabet Profile

Alphabet Inc, through its subsidiaries, provides online advertising services in the United States and internationally. The company offers performance and brand advertising services. It operates through Google and Other Bets segments. The Google segment includes principal Internet products, such as Ads, Android, Chrome, Commerce, Google Cloud, Google Maps, Google Play, Hardware, Search, and YouTube, as well as technical infrastructure and newer efforts, including Virtual Reality.

Recommended Story: Google Finance Portfolio Tips and Tricks

Want to see what other hedge funds are holding GOOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alphabet Inc (NASDAQ:GOOG).

Cramer Remix: This unlikely subscription service has others following its lead

Investors looking to seize on the rise of over-the-top streaming services and increased cord-cutting should look no further than a few key stocks, CNBC's Jim Cramer said Friday on "Mad Money."

While the devices and ecosystems that enable streaming — think Apple, Amazon, Alphabet and Comcast, as well as smaller players like Roku — are worth considering for some exposure, the streaming service providers are the real long-term winners, he said.

That's because, when it comes to over-the-top entertainment, the hardware is "not where the big money is," the longtime stock-picker explained.

"In this business, content is king," he said.

Cramer's favorite pick in the streaming space might come as a surprise: The Walt Disney Company.

But there are other surprising winners, too, including World Wrestling Entertainment, which has become something of a pioneer in its niche sports-broadcasting industry, the "Mad Money" host said.

"The truth is, tons of companies are getting into the over-the-top space," Cramer told viewers. "World Wrestling Entertainment has an incredibly successful subscription streaming service and the stock's given us some gigantic gains, nearly quadrupling over the past 18 months or so. WWE got it right and now other sports organizations are following in their footsteps."

Click here for some other ways to play the rise of streaming.

Wells Fargo CEO responds to Sen. Elizabeth Warren, talks shutdown Adam Jeffery | CNBC Tim Sloan, CEO of Wells Fargo

Wells Fargo President and CEO Tim Sloan responded Friday to Sen. Elizabeth Warren's repeated calls for his firing after a 2016 scandal in an interview on CNBC.

"She can have that opinion," Sloan, a frequent target of the Massachusetts senator and longtime Wall Street watchdog, told Cramer on "Mad Money." "I think, if I'm not doing my job, as opposed to someone having an opinion about me that isn't always an informed opinion, then, of course, it would be appropriate that I'm not in this role."

Warren, who is exploring the idea of a 2020 bid for president, asked the Federal Reserve in October to maintain its growth cap on Wells Fargo until the bank fires Sloan for his implication "in the bank's repeated and egregious misconduct."

Still, Sloan argued that he was the best man for the CEO job.

He also explained how Wells Fargo is helping customers who have been affected by the government shutdown, which President Donald Trump temporarily ended on Friday.

Click here to watch and read more about Sloan's interview.

Cramer's game plan: Coming in 'too hot?' Adam Jeffery | CNBC Tim Cook

The stock market might have run too much this week to hold its gains during next week's "earnings Super Bowl," Cramer said Friday as the Dow Jones Industrial Average rounded out its fifth straight week of gains.

"It's the busiest week of the year and we're coming in hot, maybe too hot, seeing as the market roared today on earnings and hope: hope that the government shutdown really might end, hope that we could get a trade deal with China soon, hope that the Fed won't surprise us when it meets next Wednesday," he said. "Maybe there's too much hope and too much hype."

With that possibility in mind, Cramer turned to his game plan for the week ahead, which will see earnings reports from Apple, Tesla, Facebook, General Electric, Amazon and more.

Click here for his full game plan.

Trade war talk Jason Lee | Reuters Workers walk outside a construction site in Beijing's central business district.

It's becoming increasingly clear that China has much more to lose than the United States in the countries' ongoing trade war, Cramer argued Friday.

"In the long run, it'll be cheaper for them to come to the table and give President Trump the concessions he wants," he argued.

What makes him so sure is that, stacked side by side, the Chinese and U.S. economies are in very different places. China's unemployment rate is headed towards the 5 percent level, whereas the United States' is "flirting with 3 percent," he said. The Chinese economy has slowed dramatically, while U.S. weekly jobless claims are at their lowest levels in decades.

The bottom line? From Cramer's perspective, it seems like China will eventually have to come to the table.

"We can afford to wait this out. They can't," he said. "So there should be a lot more hope that the Chinese will give in. Sooner or later, they have to."

Lightning round: Poor SCOR?

In Cramer's lightning round, he raced through his responses to callers' favorite stocks:

Comscore Inc.: "I think that this is a pyrrhic victory that they've had versus Nielsen. I don't want to touch it. It doesn't have the growth I need."

E-Trade Financial Corp.: "I think it's good. I do lament – I did a piece earlier this week about the day before Christmas and how there was just another annihilation in the stock market and more individual investors left, which makes it tougher for me to recommend any of these stocks because there are no refs in our game. No one's looking out for the little guy and it's driving me crazy."

Disclosure: Cramer's charitable trust owns shares of Apple, Amazon, Alphabet, Comcast, Disney and Facebook.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com